Our research is at the forefront of bioprinting technology, focusing on designing and printing a variety of tissues and organs using cutting-edge bioprinting methods. We specialize in developing and refining bioinks that ensure optimal cell survival, and we optimize 3D printing techniques to create complex tissues such as cornea, esophagus, liver, and bone. Additionally, we are pioneering new constructs for skin, kidney, cartilage, and heart tissues. Tailoring bioprinting methods to meet specific research needs, we carefully select the best bioprinter and materials for each project and utilize specialized bioreactors to enhance tissue maturation in the lab.
Our work goes beyond tissue fabrication, creating intricate in vitro models that are essential for drug development and assessing clinical outcomes. These models, which include skin, liver acinus, kidney glomerulus, and triple-negative breast cancer, provide crucial insights into drug efficacy and safety, advancing pharmaceutical research. By harnessing state-of-the-art bioprinting and regenerative medicine technologies, our goal is to revolutionize tissue repair, organ replacement, and drug testing, ultimately improving patient care and health outcomes.
Our well-equipped cell culture facility supports a wide range of 3D bioprinting applications, capable of working with primary cells, stem cells, and cell lines. With biosafety cabinets, incubators, and liquid nitrogen storage, we maintain a robust infrastructure for cutting-edge research in regenerative medicine.
3D Bioprinted Coenal Implants